ENHERTU fam-trastuzumab deruxtecan-nxki 20 mg/mL INJECTION FOR INTRAVENOUS USE
Faculty:Sarah JaxNurse Practitioner
Program Details:Aug 6th, 20265:30 PM - 7:30 PMCentral Standard Time
Ruths Chris20 2nd Avenue SouthwestRochester, MN 55902
RSVP:Matthew Heald(612) 618-3275matthew.heald@astrazeneca.com
By: 7/30/2026